美股三大指数集体高开，意法半导体涨超8%

Group 1 - US stock indices opened higher with Dow Jones up 0.11%, Nasdaq up 0.19%, and S&P 500 up 0.14% [1] - STMicroelectronics rose over 8% as the CEO indicated that the company will at least meet the midpoint of its performance guidance for Q2 [1] - CrowdStrike fell over 7% due to Q2 performance outlook being below expectations [1] Group 2 - Eli Lilly has signed a licensing and development agreement with Camurus to jointly develop long-acting insulin drugs for obesity, diabetes, and other metabolic diseases [2] - The agreement allows Eli Lilly to develop up to four proprietary drug compounds and Camurus is eligible for up to $870 million in potential development and sales milestone payments along with mid-single-digit royalties [2] Group 3 - AstraZeneca announced that its drug Imfinzi (durvalumab) has been approved by the National Medical Products Administration (NMPA) in China for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) who have not progressed after platinum-based chemoradiotherapy [3] Group 4 - Xunlei has completed the acquisition of Hupu's operating company, Shanghai Kuanghui Network Technology Co., Ltd., paying a cash consideration of 400 million RMB prior to the completion of the transaction [4] - Xunlei will pay the remaining 100 million RMB in two equal installments after the transaction is completed, one after 12 months and the other after 24 months [4] Group 5 - XPeng Motors and Huawei announced a strategic cooperation to be officially unveiled at a press conference on June 5 [5] - XPeng Motors' CEO He Xiaopeng had previously visited Huawei's founder Ren Zhengfei in February [5]